Financial Year |
March 31 2023 |
Monetary Funds |
11,095,370,000.00 |
Held-for-trading Financial Assets |
1,830,110,000.00 |
Notes Receivable |
198,530,000.00 |
Accounts Receivable |
6,582,040,000.00 |
Advances to Suppliers |
4,759,480,000.00 |
Other Receivables |
2,558,090,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
199,630,000.00 |
Inventories |
2,688,830,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
88,720,000.00 |
Other Current Assets |
3,016,450,000.00 |
Total Current Assets |
41,076,410,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
6,147,530,000.00 |
Investment Properties |
276,320,000.00 |
Fixed Assetes |
66,440,750,000.00 |
Under-construction Projects |
5,102,470,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
11,095,530,000.00 |
R&D expenses |
249,830,000.00 |
Goodwill |
573,850,000.00 |
Long-Term Deferred and Prepaid Expenses |
773,230,000.00 |
Deferred Income Tax Assets |
2,260,370,000.00 |
Other Non-Current Assets |
299,230,000.00 |
Sub-Total of Non-Current Assets |
98,219,970,000.00 |
Total Assets |
139,296,380,000.00 |
Short-Term Loans |
9,910,770,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
843,830,000.00 |
Accounts Payable |
10,281,080,000.00 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
660,400,000.00 |
Taxes Payable |
2,671,880,000.00 |
Interest Payable |
-- |
Dividend Payable |
357,880,000.00 |
Other payables |
2,094,040,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,400,460,000.00 |
Other Current Liabilities |
1,527,890,000.00 |
Sub-Total of Current Liabilities |
49,307,840,000.00 |
Long-term Loans |
12,134,180,000.00 |
Bonds Payable |
14,202,440,000.00 |
Long-Term Accounts Payable |
1,455,100,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
3,691,930,000.00 |
Other Non-Current Liabilities |
2,844,590,000.00 |
Sub-Total of Non-Current Liabilities |
35,715,870,000.00 |
Total Liabilities |
85,023,710,000.00 |
Paid-In Capital(Or Share Stock) |
3,098,400,000.00 |
Capital Surplus |
207,030,000.00 |
Surplus Reserve |
331,110,000.00 |
LESS:Treasury Stock |
190,010,000.00 |
Undistributed Profits |
14,901,300,000.00 |
Minority Stockholder's Interest |
35,123,400,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,149,270,000.00 |
Owner's Equity(Stockholder's Equity) |
54,272,670,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
139,296,380,000.00 |